Novartis Sues To Reverse USPTO Judgment

Law360 (January 9, 2007, 12:00 AM EST) -- A Novartis AG subsidiary has filed a federal lawsuit against two French research institutions, seeking to overturn an unfavorable judgment in a patent interference proceeding before a U.S. Patent and Trademark Office board.

The lawsuit, filed on Friday by California-based Novartis Vaccines and Diagnostics Inc., names the Institut Pasteur and Centre Nationale De La Recherche Scientifique as defendants.

Pursuant to 35 U.S.C. section 146, any party to a USPTO interference can file a civil action seeking review of the USPTO’s decision within 60 days of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.